Clinical Research
Clinical Trials in Abdominal Transplantation
Clinical trials within the Divison of Abdominal Transplantation include: Tolerance Induction, EVB-induced post-transplant lymphoma, and the following Stanford-based trials for liver, kidney, intestine, pacreas, diabetes, and hepatocellular carcinoma.
This page provides an auto-populated up-to-date list of Stanford Clinical Trials in: liver, kidney, intestine, pancreas, diabetes, hepatocellular carcinoma, and pediatric transplant.
-
The Insulin-Only Bionic Pancreas Bridging Study
Stanford is currently accepting patients for this trial. -
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Stanford is currently accepting patients for this trial. -
TrialNet Pathway to Prevention of T1D
Stanford is currently accepting patients for this trial. -
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Stanford is currently accepting patients for this trial. -
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Stanford is currently accepting patients for this trial. -
Glycemic Control and the Brain in Children With Type 1 Diabetes
Stanford is currently accepting patients for this trial. -
ATG-GCSF in New Onset Type 1 Diabetes
Stanford is currently accepting patients for this trial.